Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Polymer Drug Conjugates Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Polymer Drug Conjugates Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Polymer-Dox Conjugates
      • 1.3.3 Polymer-Paclitaxel Conjugates
      • 1.3.4 Polymer-Camptothecin Conjugates
      • 1.3.5 Polymer-Platinate Conjugates
    • 1.4 Market Segment by Application
      • 1.4.1 Global Polymer Drug Conjugates Market Share by Application (2019-2025)
      • 1.4.2 Cancer Treatment
      • 1.4.3 Leukmia
      • 1.4.4 Hepatitis
      • 1.4.5 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Polymer Drug Conjugates Market Size
      • 2.1.1 Global Polymer Drug Conjugates Revenue 2014-2025
      • 2.1.2 Global Polymer Drug Conjugates Sales 2014-2025
    • 2.2 Polymer Drug Conjugates Growth Rate by Regions
      • 2.2.1 Global Polymer Drug Conjugates Sales by Regions 2014-2019
      • 2.2.2 Global Polymer Drug Conjugates Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Polymer Drug Conjugates Sales by Manufacturers
      • 3.1.1 Polymer Drug Conjugates Sales by Manufacturers 2014-2019
      • 3.1.2 Polymer Drug Conjugates Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Polymer Drug Conjugates Revenue by Manufacturers (2014-2019)
      • 3.2.2 Polymer Drug Conjugates Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Polymer Drug Conjugates Market Concentration Ratio (CR5 and HHI)
    • 3.3 Polymer Drug Conjugates Price by Manufacturers
    • 3.4 Key Manufacturers Polymer Drug Conjugates Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Polymer Drug Conjugates Market
    • 3.6 Key Manufacturers Polymer Drug Conjugates Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Polymer-Dox Conjugates Sales and Revenue (2014-2019)
      • 4.1.2 Polymer-Paclitaxel Conjugates Sales and Revenue (2014-2019)
      • 4.1.3 Polymer-Camptothecin Conjugates Sales and Revenue (2014-2019)
      • 4.1.4 Polymer-Platinate Conjugates Sales and Revenue (2014-2019)
    • 4.2 Global Polymer Drug Conjugates Sales Market Share by Type
    • 4.3 Global Polymer Drug Conjugates Revenue Market Share by Type
    • 4.4 Polymer Drug Conjugates Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Polymer Drug Conjugates Sales by Application

    6 United States

    • 6.1 United States Polymer Drug Conjugates Breakdown Data by Company
    • 6.2 United States Polymer Drug Conjugates Breakdown Data by Type
    • 6.3 United States Polymer Drug Conjugates Breakdown Data by Application

    7 European Union

    • 7.1 European Union Polymer Drug Conjugates Breakdown Data by Company
    • 7.2 European Union Polymer Drug Conjugates Breakdown Data by Type
    • 7.3 European Union Polymer Drug Conjugates Breakdown Data by Application

    8 China

    • 8.1 China Polymer Drug Conjugates Breakdown Data by Company
    • 8.2 China Polymer Drug Conjugates Breakdown Data by Type
    • 8.3 China Polymer Drug Conjugates Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Polymer Drug Conjugates Breakdown Data by Company
    • 9.2 Rest of World Polymer Drug Conjugates Breakdown Data by Type
    • 9.3 Rest of World Polymer Drug Conjugates Breakdown Data by Application
    • 9.4 Rest of World Polymer Drug Conjugates Breakdown Data by Countries
      • 9.4.1 Rest of World Polymer Drug Conjugates Sales by Countries
      • 9.4.2 Rest of World Polymer Drug Conjugates Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 3S Bio
      • 10.1.1 3S Bio Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Polymer Drug Conjugates
      • 10.1.4 Polymer Drug Conjugates Product Introduction
      • 10.1.5 3S Bio Recent Development
    • 10.2 Abeona Therapeutics
      • 10.2.1 Abeona Therapeutics Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Polymer Drug Conjugates
      • 10.2.4 Polymer Drug Conjugates Product Introduction
      • 10.2.5 Abeona Therapeutics Recent Development
    • 10.3 Abramson Cancer Center
      • 10.3.1 Abramson Cancer Center Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Polymer Drug Conjugates
      • 10.3.4 Polymer Drug Conjugates Product Introduction
      • 10.3.5 Abramson Cancer Center Recent Development
    • 10.4 Access Pharmaceuticals
      • 10.4.1 Access Pharmaceuticals Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Polymer Drug Conjugates
      • 10.4.4 Polymer Drug Conjugates Product Introduction
      • 10.4.5 Access Pharmaceuticals Recent Development
    • 10.5 Adama
      • 10.5.1 Adama Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Polymer Drug Conjugates
      • 10.5.4 Polymer Drug Conjugates Product Introduction
      • 10.5.5 Adama Recent Development
    • 10.6 Eyetech
      • 10.6.1 Eyetech Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Polymer Drug Conjugates
      • 10.6.4 Polymer Drug Conjugates Product Introduction
      • 10.6.5 Eyetech Recent Development
    • 10.7 Ferring
      • 10.7.1 Ferring Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Polymer Drug Conjugates
      • 10.7.4 Polymer Drug Conjugates Product Introduction
      • 10.7.5 Ferring Recent Development
    • 10.8 Flamel Technologies
      • 10.8.1 Flamel Technologies Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Polymer Drug Conjugates
      • 10.8.4 Polymer Drug Conjugates Product Introduction
      • 10.8.5 Flamel Technologies Recent Development
    • 10.9 Genentech
      • 10.9.1 Genentech Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Polymer Drug Conjugates
      • 10.9.4 Polymer Drug Conjugates Product Introduction
      • 10.9.5 Genentech Recent Development
    • 10.10 GlaxoSmithKline
      • 10.10.1 GlaxoSmithKline Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Polymer Drug Conjugates
      • 10.10.4 Polymer Drug Conjugates Product Introduction
      • 10.10.5 GlaxoSmithKline Recent Development
    • 10.11 Gowan
    • 10.12 Gynecologic Oncology Group Foundation
    • 10.13 JenKem Technology
    • 10.14 Landec
    • 10.15 Lipotek

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Polymer Drug Conjugates Sales Channels
      • 11.2.2 Polymer Drug Conjugates Distributors
    • 11.3 Polymer Drug Conjugates Customers

    12 Market Forecast

    • 12.1 Global Polymer Drug Conjugates Sales and Revenue Forecast 2019-2025
    • 12.2 Global Polymer Drug Conjugates Sales Forecast by Type
    • 12.3 Global Polymer Drug Conjugates Sales Forecast by Application
    • 12.4 Polymer Drug Conjugates Forecast by Regions
      • 12.4.1 Global Polymer Drug Conjugates Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Polymer Drug Conjugates Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Polymer Drug Conjugates is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Polymer Drug Conjugates.

      This report studies the global market size of Polymer Drug Conjugates, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Polymer Drug Conjugates sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      3S Bio
      Abeona Therapeutics
      Abramson Cancer Center
      Access Pharmaceuticals
      Adama
      Eyetech
      Ferring
      Flamel Technologies
      Genentech
      GlaxoSmithKline
      Gowan
      Gynecologic Oncology Group Foundation
      JenKem Technology
      Landec
      Lipotek

      Market Segment by Product Type
      Polymer-Dox Conjugates
      Polymer-Paclitaxel Conjugates
      Polymer-Camptothecin Conjugates
      Polymer-Platinate Conjugates

      Market Segment by Application
      Cancer Treatment
      Leukmia
      Hepatitis
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Polymer Drug Conjugates status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Polymer Drug Conjugates manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Polymer Drug Conjugates are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now